NA
Naveed Aziz
Genome Canada
Vice-President for Research and Innovation
Description
As Vice-President of Research and Innovation (VPRI) at Genome Canada, Dr. Naveed Aziz leads the design and implementation of the organization's research programs, challenges, and initiatives. He plays a pivotal role in contributing to shaping and executing Genome Canada’s vision, mission, strategy, and objectives.
With over 20 years of expertise in the field of genomics, Dr. Aziz is a drives genomic innovation at Genome Canada. He champions mission-driven challenges and strategic initiatives, fueled by a deep interest in leveraging genomics to address global issues and a passion for developing big data generation solutions.
Before his tenure at Genome Canada, Dr. Aziz served as the Chief Executive Officer of CGEn, Canada’s national platform for genome sequencing & analysis with nodes at The Hospital for Sick Children (Toronto), McGill University (Montréal) and Canada’s Michael Smith Genome Sciences Centre (Vancouver). In this role, he facilitated Canadian leadership in both fundamental and applied genomics research. His contributions were instrumental in advancing technological developments and providing solutions to global challenges in health, agriculture, and related sectors.
Previously, Dr. Aziz served as the Director of Technology programs at Genome Canada. In this role, he led Genome Canada’s portfolio of technology programs with the primary goal to help create opportunities that promote innovation and develop new national capacity in genomics, big data, and related sciences. He has also served as the Head of Genomics at University of York, UK and as a Research Fellow at the Noble Research Institute, USA.
Dr. Aziz has represented Canada on several national and international committees, including the United Kingdom Ministry of Science and Innovation and the Organization for Economic Co-operation and Development. Through these roles, he shared his expertise, insights, and best practices with global peers. Recognized for his visionary thinking, strategic planning, and exceptional execution, Dr. Aziz has received numerous honors. He was awarded the Canadian Association of Research Administrators' 2022 Research Partnership Award, named one of Canada’s Emerging Executive Leaders by adMare BioInnovations and Pfizer in 2018, and profiled as one of Canada’s Top 20 Dynamic CEOs in 2021.
Dr. Aziz earned his PhD in Gene Targeting from the University of Dundee, United Kingdom, through the Commonwealth Fulbright Scholarship program. He holds a Master of Philosophy in Biotechnology from Quaid-i-Azam University in Islamabad and an Executive MBA from the Bradford School of Management, United Kingdom. Additionally, he completed a Research Fellowship at the Noble Research Institute and graduated from the executive training program at Harvard Business School in the United States.
Loading